What this study is
The general objective of this study is to evaluate the clinical impact and safety of focused, point-of-care transesophageal echocardiography (TEE) used during the evaluation of critically-ill patients in the emergency and intensive care settings. The target population for this study are critically-ill patients over the age of 18 who as part of their routine clinical care are receiving a focused TEE.
The primary objective of this study is to determine the clinical impact and safety of TEE performed during the evaluation of critically-ill patients in the emergency department and intensive care settings.
The secondary objective(s) of this study are to characterize the use of this imaging modality in the subsets of critically-ill patients in shock and cardiac arrest; including but not limited to; description of the frequency of studies, clinical indications, clinician characteristics, echocardiography findings, timing of studies, procedure-related complications and patient outcomes.
Study details
- Official title
- Evaluation of the Clinical Impact and Safety of Focused Transesophageal Echocardiography During Resuscitation of Critically Ill Patients in the Emergency Department and Intensive Care Settings
- Sponsor
- University of Pennsylvania
- Conditions
- Cardiac Arrest · Cardiac Arrest Circulatory · Cardiac Arrest, Out-Of-Hospital · Shock · Hemodynamic Instability
- Enrolling
- 1,000 people
- Starts
- 2020-12-01
- Est. completion
- 2027-12-15
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Adult critically-ill patients who as part of their routine clinical care receive focused TEE in the emergency department of intensive care setting.
You can't join if
- Children (age under 18 years)
- Vulnerable populations
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openRush University Medical Center
Chicago, Illinois, United States
- Michelle Santangelo, MS · Contact7175792198Michelle_Santangelo@rush.edu
- Felipe Teran, MD, MSCE · Principal investigator
Recruiting
Study team
Sponsor
University of Pennsylvania
Study ID 844522
Principal investigator
Felipe Teran, MD, MSCE
Weill Medical College of Cornell University
Study chair
Clark G Owyang, MD
Weill Medical College of Cornell University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.